Edgewise Therapeutics announced that Michael Nofi will assume the role of Chief Financial Officer, effective November 10 2025, succeeding retiring CFO R. Michael Carruthers. Nofi brings more than three decades of finance leadership in the life‑sciences sector, having served as Chief Accounting Officer at SpringWorks Therapeutics for six years and as Vice President of Global Accounting and Corporate FP&A at The Nature’s Bounty Co. His track record includes scaling finance operations from research and development to full commercialization, a skill set that Edgewise will leverage as it advances late‑stage clinical programs and prepares for potential product launches.
Edgewise’s financial position remains robust, with a net loss of $40.7 million in the third quarter of 2025 and $36.1 million in the second quarter, reflecting the company’s continued investment in its lead candidates. Despite these losses, the company maintains a strong cash reserve that supports its capital‑intensive pipeline, which includes sevasemten for Becker and Duchenne muscular dystrophies and EDG‑7500 for hypertrophic cardiomyopathy. The appointment of Nofi is intended to strengthen financial stewardship, enhance capital planning, and ensure disciplined budgeting as the company moves toward commercialization milestones.
CEO Kevin Koch emphasized the strategic importance of the new hire, stating, “As we enter a pivotal stage in our company’s evolution, we are thrilled to welcome Michael Nofi to the Edgewise team. His extensive experience in financial leadership and commercialization readiness will be instrumental as we advance our late‑stage development programs.” Koch added that the company’s strong balance sheet and progress in cardiac and skeletal muscle programs provide a solid foundation for future growth.
Market participants responded positively to the CFO appointment, citing the combination of Nofi’s expertise, Edgewise’s solid financial footing, and the momentum of its clinical pipeline as key drivers of confidence in the company’s trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.